Anti-Porphyromonas gingivalis Antibodies in Rheumatoid Arthritis: Comment on the Article by Seror et al

Related Experiment Videos

Kulveer Mankia^1,2, Paul Emery^1,2

¹Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK.

Arthritis & Rheumatology (Hoboken, N.J.)

|August 29, 2015

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Type I interferon activation in classical monocytes and GZMK+ CD8+ T cells characterises the ultrasound-negative phase of imminent rheumatoid arthritis.

Annals of the rheumatic diseases·2026

Targeted anti-CCP testing to identify people at risk of rheumatoid arthritis in primary care: an early economic evaluation.

Rheumatology advances in practice·2026

MRI and ultrasound predictors of progression to inflammatory arthritis in anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis: a prospective cohort study.

Annals of the rheumatic diseases·2026

Risk prediction rules in individuals at risk of rheumatoid arthritis: systematic review and validation using the APIPPRA cohort.

EULAR rheumatology open·2026

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease.

Annals of the rheumatic diseases·2026

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase.

Rheumatology (Oxford, England)·2026

See all related articles